FDA Approves First-of-its-Kind Intentional Genomic Alteration in Line of Domestic Pigs

FDA Approves First-of-its-Kind Intentional Genomic Alte

Field Notes, powered by KPMG, is a weekly news update on news nationally and globally from the agri-food sector.

1000
Ian Proudfoot

Global Head of Agribusiness, Partner - Audit

KPMG in New Zealand

Email

Also on home.kpmg

genomic-alternation

[14 December, PR Newswire]

The US Food and Drug Administration (FDA) approved an intentional genomic alteration (IGA) in a line of domestic pigs, referred to as GalSafe pigs. The IGA is intended to eliminate alpha-gal sugar on the surface of the pigs' cells in order to reduce the allergic reactions from people with Alpha-gal syndrome when consuming red meat. This is a first-of-its-kind IGA approved by the FDA for the purpose of food consumption and as a source for potential therapeutic uses.

To read this week's full edition of Field Notes, please click here.

To read the full original article, please click here.


 

© 2021 KPMG, a New Zealand Partnership and a member firm of the KPMG global organisation of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. All rights reserved.


For more detail about the structure of the KPMG global organization please visit https://home.kpmg/governance.

Connect with us

 

Want to do business with KPMG?

 

loading image Request for proposal